VitaNova Life Sciences (VNOV) Gross Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Gross Margin came in at 9.49% in Q3 2026, down 5671.0% YoY from 0.17% in Q3 2025, and down 35.99% on a QoQ basis from 14.83% in Q2 2026.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Gross Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed Gross Margin across 4 years of filings, most recently posting 9.49% for Q3 2026.
- Gross Margin for Q3 2026 came in at 9.49%, down 5671.0% year-over-year; the trailing twelve-month figure through Jul 2026 was 26.9% (down 3223.0% YoY), and the FY2026 annual result was 30.1%, down 2909.0% from the prior year.
- Gross Margin for Q3 2026 stood at 9.49%, down from 14.83% in the prior quarter.
- Across five years, Gross Margin topped out at 100.0% in Q1 2024 and bottomed at 9.49% in Q3 2026.
- Average Gross Margin over 3 years is 54.74%, with a median of 61.06% recorded in 2025.
- The widest annual swing landed in 2025, when Gross Margin soared 772 bps; it then tumbled 5671 bps in 2026.
- Year by year, Gross Margin stood at 53.35% in 2024, then climbed by 14 bps to 61.06% in 2025, then plunged by 84 bps to 9.49% in 2026.
- The last three Gross Margin figures came in at 9.49% (Q3 2026), 14.83% (Q2 2026), and 44.58% (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 32.77% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 51.10% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 70.95% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 52.29% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 18.59% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 36.50% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 77.29% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 31.84% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 89.10% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | 9.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 14.83% |
| Jan 31, 2026 | 44.58% |
| Oct 31, 2025 | 61.06% |
| Jul 31, 2025 | 66.20% |
| Apr 30, 2025 | 59.26% |
| Jan 31, 2025 | 61.40% |
| Oct 31, 2024 | 53.35% |
| Jul 31, 2024 | 67.45% |
| Apr 30, 2024 | 64.56% |
| Jan 31, 2024 | 100.00% |
| Jul 31, 2017 | 84.24% |